CHC MontLegia — Clinical Trial Site

124 Registered trials

65 Currently recruiting

Organisation

CHC MontLegia

Location

Liege, Belgium

Identifier

ORG-100043333

Address

Boulev. De Patience Et Beajonc 2, 4000, Belgium

Departments

#1003: medical oncology
032005: Pediatric gastroenterology
032007:Oncologie - Hémato-Immunopatho
Breast Hemoto-oncology clinic
Cardiology
Cardiology Department
Center for Reproductive Medicine
Département d'Oncologie/Hématologie
Département d'Oncologie/Hématologie Adulte
Département de Pédiatrie
Department Hématologie et oncologie pédiatrique
Department of Gastroenterology
Department of hemato-oncology
Department of Oncology
Department of Pediatric Hemato-Oncology
Gastro-entérologie
Gastro-enterology
Gastro-enterology and hemato-oncology
Gastro-oncology
Gastroenterology
Gastropediatric
Gastropediatric department
Groupe Sante CHC - Clinique du MontLegia
Groupe Santé CHC Montlégia
Gynécologie-obstétrique
Gynecology
Hémato - oncologie pédiatrique
Hemato - Oncology
Hemato Oncology
Hemato-Oncologie
Hemato-Oncology
Hematology
Hematology Department
Intensive care
Interventional cardiology and intensive care
Medical Oncology
NA
Neonatal Intensive Care Unit
Néphrologie pédiatrique
Neurolog
Neurology
Neurology Department
Oncologie
Oncologie médicale
Oncology
Oncology - Hematology Department
Oncology for pediatrics
Paediatric haemato oncology
Paediatric haemato-oncology
Paediatric Haematology and oncology
Pediatric Cardiology
Pediatric Haemato-oncology
Pediatric Hemato-Oncology
Pediatric hematology and oncology
Pediatric Oncology and Hematology
Pediatrics
Pediatry
Pulmonology

Clinical trials at this site (124)

Search interface

Hypertonic lactate after cardiac arrest Recruiting

2023-506031-15-01 post-anoxic brain injury 4 2025-02-18
A trial to learn if Dato-DXd with rilvegostomig, or rilvegostomig alone, is safe and works compared with pembrolizumab in people who have ad… Recruiting

2023-505077-32-00 Locally-advanced or metastatic non-squamous non-small c 5 2025-01-28
ZELA trial: Phase 2b/3 Multicenter Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developi… Recruiting

2024-513420-41-00 prematurity in neonates 10 2025-01-09
A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 … Recruiting

2024-513441-36-00 MMRp/ MSS colon cancer 4 2024-11-27
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting

2024-513009-30-00 Moderate to Severe Crohn’s Disease 4 2024-11-21
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f… Recruiting

2024-510892-40-00 Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
An international randomised trial of radical surgery followed by adjuvant therapy versus no further treatment in patients with early-stage, … Recruiting

2023-504973-19-01 early-stage, intermediate-risk cervical cancer 5 2023-09-06
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Acute Myeloid Leukemia 5 2023-07-14
Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting

2022-501710-62-02 Peripheral T-cell lymphoma (PTCL) 6 2023-06-07
Preoperative treatment with mFOLFIRINOX (or Gem-Nab-P) +/- isotoxic high-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for borderline … Recruiting

2022-501181-22-01 Pancreatic adenocarcinoma 4 2023-02-06
WOEST-3 Recruiting

2022-502140-13-00 Atrial fibrillation Acute coronary syndrome Chronic cor 6 2023-01-11
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece… Recruiting

2023-504885-50-00 Treatment of children with chronic kidney disease and p 5 2022-11-07
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC… Recruiting

2024-516336-97-00 METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA 4 2022-02-21
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 atypical teratoid/rhabdoid tumours (ATRT) 5 2020-07-20
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01